최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Oncogenesis, v.9 no.1, 2020년, pp.1 -
Im, Joo-Young (Personalized Genomic Medicine Research Center, KRIBB, Daejeon, 34141 Korea) , Kim, Bo-Kyung (Personalized Genomic Medicine Research Center, KRIBB, Daejeon, 34141 Korea) , Lee, Kang-Woo (Department of Oriental Medicine, Daejeon University, Daehak-ro 62, Dong-gu, Daejeon, 34520 South Korea) , Chun, So-Young (Personalized Genomic Medicine Research Center, KRIBB, Daejeon, 34141 Korea) , Kang, Mi-Jung (Personalized Genomic Medicine Research Center, KRIBB, Daejeon, 34141 Korea) , Won, Misun (Personalized Genomic Medicine Research Center, KRIBB, Daejeon, 34141 Korea)
DNA damage-induced apoptosis suppressor (DDIAS) regulates cancer cell survival. Here we investigated the involvement of DDIAS in IL-6–mediated signaling to understand the mechanism underlying the role of DDIAS in lung cancer malignancy. We showed that DDIAS promotes tyrosine phosphorylation o...
1. Chang CH Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy Int. J. Cancer 2013 132 1977 1985 23034889
2. Yanagawa H Serum levels of interleukin 6 in patients with lung cancer Br. J. Cancer 1995 71 1095 1098 7734307
3. Gao SP Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas J. Clin. Invest. 2007 117 3846 3856 18060032
4. Yao X Targeting interleukin-6 in inflammatory autoimmune diseases and cancers Pharm. Ther. 2014 141 125 139
5. Yao Z TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer Proc. Natl Acad. Sci. USA 2010 107 15535 15540 20713723
6. Bromberg JF Stat3 as an oncogene Cell 1999 98 295 303 10458605
7. Yu H Jove R The STATs of cancer-new molecular targets come of age Nat. Rev. Cancer 2004 4 97 105 14964307
8. Yu H Pardoll D Jove R STATs in cancer inflammation and immunity: a leading role for STAT3 Nat. Rev. Cancer 2009 9 798 809 19851315
9. Yeh HH Lai WW Chen HH Liu HS Su WC Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion Oncogene 2006 25 4300 4309 16518408
10. Harada D Takigawa N Kiura K The role of STAT3 in non-small cell lung cancer Cancers (Basel) 2014 6 708 722 24675568
11. Bhattacharya S Ray RM Johnson LR STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells Biochem. J. 2005 392 335 344 16048438
12. Gritsko T Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells Clin. Cancer Res. 2006 12 11 19 16397018
13. Masuda M The roles of JNK1 and Stat3 in the response of head and neck cancer cell lines to combined treatment with all-trans-retinoic acid and 5-fluorouracil Jpn J. Cancer Res. 2002 93 329 339 11927016
14. Xie TX Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis Oncogene 2004 23 3550 3560 15116091
15. Zhang X Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts Proc. Natl Acad. Sci. USA 2012 109 9623 9628 22623533
16. Tonks NK Protein tyrosine phosphatases: from genes, to function, to disease Nat. Rev. Mol. Cell Biol. 2006 7 833 846 17057753
17. Tonks NK Protein tyrosine phosphatases-from housekeeping enzymes to master regulators of signal transduction FEBS J. 2013 280 346 378 23176256
18. Sekine Y Regulation of STAT3-mediated signaling by LMW-DSP2 Oncogene 2006 25 5801 5806 16636663
19. Yamamoto T The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation Biochem. Biophys. Res. Commun. 2002 297 811 817 12359225
20. Bard-Chapeau EA Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis Cancer Cell 2011 19 629 639 21575863
21. Zhang X Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T Proc. Natl Acad. Sci. USA 2007 104 4060 4064 17360477
22. Chen YW Receptor-type tyrosine-protein phosphatase kappa directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma Blood 2015 125 1589 1600 25612622
23. Veeriah S The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers Proc. Natl Acad. Sci. USA 2009 106 9435 9440 19478061
24. Lui VW Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer Proc. Natl Acad. Sci. USA 2014 111 1114 1119 24395800
25. Chung CD Specific inhibition of Stat3 signal transduction by PIAS3 Science 1997 278 1803 1805 9388184
26. Liu B Inhibition of Stat1-mediated gene activation by PIAS1 Proc. Natl Acad. Sci. USA 1998 95 10626 10631 9724754
27. Calvisi DF Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma J. Clin. Invest. 2007 117 2713 2722 17717605
28. Puhr M SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling Endocr. Relat. Cancer 2010 17 525 538 20335309
29. Tang Q Jiang J Liu J CCR5 blockade suppresses melanoma development through inhibition of IL-6-Stat3 pathway via upregulation of SOCS3 Inflammation 2015 38 2049 2056 26047948
30. Yeh JE Frank DA STAT3-interacting proteins as modulators of transcription factor function: implications to targeted cancer therapy ChemMedChem 2016 11 795 801 26662504
31. Wang T Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells Oncotarget 2015 6 30975 30992 26307676
32. Wang Y GdX/UBL4A specifically stabilizes the TC45/STAT3 association and promotes dephosphorylation of STAT3 to repress tumorigenesis Mol. Cell 2014 53 752 765 24530303
33. Im JY DNA damage-induced apoptosis suppressor (DDIAS), a novel target of NFATc1, is associated with cisplatin resistance in lung cancer Biochim. Biophys. Acta 2016 1863 40 49 26493727
34. Im JY DNA damage induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes beta-catenin-mediated invasion Biochim. Biophys. Acta 2016 1859 1449 1458 27412911
35. Won KJ Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells Cell Death Dis. 2017 8 e2554 28079882
36. Im JY DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells Oncogene 2018 37 1251 1262 29242605
37. Zhang ZZ Huang J Wang YP Cai B Han ZG NOXIN as a cofactor of DNA polymerase-primase complex could promote hepatocellular carcinoma Int. J. Cancer 2015 137 765 775 25612832
38. Won KJ Human Noxin is an anti-apoptotic protein in response to DNA damage of A549 non-small cell lung carcinoma Int. J. Cancer 2014 134 2595 2604 24214091
39. Yuan ZL Guan YJ Chatterjee D Chin YE Stat3 dimerization regulated by reversible acetylation of a single lysine residue Science 2005 307 269 273 15653507
40. Sobotta MC Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling Nat. Chem. Biol. 2015 11 64 70 25402766
41. Wei J The ubiquitin ligase TRAF6 negatively regulates the JAK-STAT signaling pathway by binding to STAT3 and mediating its ubiquitination PLoS ONE 2012 7 e49567 23185365
42. Zhong Z Wen Z Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 Science 1994 264 95 98 8140422
43. Garcia R Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells Oncogene 2001 20 2499 2513 11420660
44. Wang Z Mutational analysis of the tyrosine phosphatome in colorectal cancers Science 2004 304 1164 1166 15155950
45. LaForgia S Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21 Proc. Natl Acad. Sci. USA 1991 88 5036 5040 1711217
46. Yu, C. et al. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway. Cell Prolif. 10.1111/cpr.12610.e12610 (2019).
47. Gebbink MF Cell surface expression of receptor protein tyrosine phosphatase RPTP mu is regulated by cell-cell contact J. Cell Biol. 1995 131 251 260 7559782
48. Sun PH Ye L Mason MD Jiang WG Protein tyrosine phosphatase micro (PTP micro or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis PLoS ONE 2012 7 e50183 23185569
49. Sudhir PR Loss of PTPRM associates with the pathogenic development of colorectal adenoma-carcinoma sequence Sci. Rep. 2015 5 9633 25910225
50. Burgoyne AM Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration Cancer Res. 2009 69 6960 6968 19690139
51. Stevenson WS DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia Leukemia 2014 28 787 793 24045499
52. Quintavalle C miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPmu Oncogene 2012 31 858 868 21743492
53. Neel BG Tonks NK Protein tyrosine phosphatases in signal transduction Curr. Opin. Cell Biol. 1997 9 193 204 9069265
54. Zondag GC Reynolds AB Moolenaar WH Receptor protein-tyrosine phosphatase RPTPmu binds to and dephosphorylates the catenin p120(ctn) J. Biol. Chem. 2000 275 11264 11269 10753936
55. Mariner DJ Davis MA Reynolds AB EGFR signaling to p120-catenin through phosphorylation at Y228 J. Cell Sci. 2004 117 1339 1350 14996911
56. Alema S Salvatore AM p120 catenin and phosphorylation: mechanisms and traits of an unresolved issue Biochim. Biophys. Acta 2007 1773 47 58 16904204
57. Vichai V Kirtikara K Sulforhodamine B colorimetric assay for cytotoxicity screening Nat. Protoc. 2006 1 1112 1116 17406391
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.